| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.29 | 9e-22 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.12 | 5e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |